This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Allegra, C. J. Articles by Boarman, D. Search for Related Content PubMed Articles by Allegra, C. J. Articles by Boarman, D.

Interaction of Methotrexate Polyglutamates and Dihydrofolate during Leucovorin Rescue in a Human Breast Cancer Cell Line (MCF-7)

Medicine Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892

Previous investigations have suggested that high-dose methotrexate with leucovorin rescue is a potentially useful strategy for overcoming antifolate resistance. Interactions between methotrexate (MTX) and leucovorin and their respective metabolites appear to occur at multiple intracellular sites, including dihydrofolate reductase (MTX/MTX polyglutamates versus dihydrofolate) and other folate-dependent enzymes (MTX polyglutamates versus reduced folate substrates). The present studies were designed to test the ability of dihydrofolate to compete with methotrexate and methotrexate polyglutamates for dihydrofolate reductase activity using an intact human breast carcinoma cell line (MCF-7) as the model system. Exposure of the breast cells to methotrexate for 24 h resulted in a concentration-dependent formation of methotrexate polyglutamates that markedly exceeded the dihydrofolate reductase-binding capacity for up to 24 h after the removal of drug from the growth media. Under these conditions of dihydrofolate reductase inhibition, we found that tritium-labeled dihydrofolate was capable of competing with methotrexate and its metabolites for dihydrofolate reductase activity as evidenced by the appearance of tritium-labeled reduced folates in the treated cells. We found the interaction between dihydrofolate and methotrexate to be dependent on the exposure concentrations of both methotrexate and dihydrofolate. These studies provide direct evidence that competition during leucovorin rescue occurs at the level of dihydrofolate reductase between methotrexate polyglutamates and dihydrofolate polyglutamates in intact human cells.

¹ To whom requests for reprints should be addressed, at Building 10, Room 12N226, National Cancer Institute, Bethesda, MD 20892.

Received 9/28/89. Revised 2/26/90.

This article has been cited by other articles:

				T. Dervieux, D. Orentas Lein, J. Marcelletti, K. Pischel, K. Smith, M. Walsh, and R. Richerson HPLC Determination of Erythrocyte Methotrexate Polyglutamates after Low-Dose Methotrexate Therapy in Patients with Rheumatoid Arthritis Clin. Chem., October 1, 2003; 49(10): 1632 - 1641. [Abstract] [Full Text] [PDF]